With a global capacity of more than 1,200,000 square feet, our network of 28 laboratories operates under the same strict quality procedures and LIMS worldwide.
Eurofins BioPharma Product Testing is the largest network of bio/pharmaceutical GMP product testing laboratories providing comprehensive laboratory services for the world’s largest bio/pharmaceutical companies. With a global capacity of more than 1,200,000 square feet, our network of 28 laboratories operates under the same strict quality procedures and LIMS worldwide.
Eurofins BioPharma Product Testing provides testing services for all stages of the drug development process and supports all functional areas of bio/pharmaceutical manufacturing, including method development, microbiology, process validation and quality control. We offer clients the flexibility to choose from three service models, including our award-winning PSS Insourcing Solutions.
Eurofins BioPharma Product Testing
2425 New Holland Pike, Lancaster, PA 17601
pharma@eurofins.com
tel. 717.656.2300
BIO International Booth #327
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.